Page last updated: 2024-11-01

ofloxacin and Uveomeningoencephalitic Syndrome

ofloxacin has been researched along with Uveomeningoencephalitic Syndrome in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Uveomeningoencephalitic Syndrome: A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. (Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39(4):265-292)

Research Excerpts

ExcerptRelevanceReference
"To describe a case of virus-associated hemophagocytic syndrome with ocular changes resembling Vogt-Koyanagi-Harada disease prior to the systemic changes."1.38Ocular findings in a patient with virus-associated hemophagocytic syndrome. ( Cheng, Y; Ding, W; Liu, Y; Xu, Y; Yao, H, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yao, H1
Liu, Y1
Ding, W1
Xu, Y1
Cheng, Y1

Other Studies

1 other study available for ofloxacin and Uveomeningoencephalitic Syndrome

ArticleYear
Ocular findings in a patient with virus-associated hemophagocytic syndrome.
    Ocular immunology and inflammation, 2012, Volume: 20, Issue:3

    Topics: Antiviral Agents; Cytomegalovirus Infections; Dexamethasone; Drug Therapy, Combination; Fatal Outcom

2012